A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/ betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP)
SourceBritish Journal of Dermatology, 177, 1, (2017), pp. 197-205
Article / Letter to editor
Display more detailsDisplay less details
British Journal of Dermatology
Upload full text
Use your RU credentials (u/z-number and password) tolog in with SURFconextto upload a file for processing by the repository team.